Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Costanza Rovida

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
ALTEX|May 14, 2013
Alternative in vitro methods to characterize the role of Endocrine Active Substances (EASs) in hormone-targeted tissuesCostanza Rovida, Isabella De Angelis, Stefano Lorenzetti
ALTEX|December 2, 2011
How are reproductive toxicity and developmental toxicity addressed in REACH dossiers?Costanza Rovida, Fabiola Longo, Richard R Rabbit
ALTEX|October 10, 2025
Fish count, too - The animal toll of REACH aquatic toxicity testsJean Knight, Costanza Rovida, Kate Willett, et al.
Alternatives to Laboratory Animals : ATLA|June 6, 2014
ESNATS conference - the use of human embryonic stem cells for novel toxicity testing approachesCostanza Rovida, Manon Vivier, Bernward Garthoff, et al.
ALTEX|July 20, 2023
REACH out-numbered! The future of REACH and animal numbersCostanza Rovida, Francois Busquet, Marcel Leist, et al.
ALTEX|July 16, 2018
Animal testing and its alternatives - the most important omics is economicsLucy Meigs, Lena Smirnova, Costanza Rovida, et al.
Archives of Toxicology|May 25, 2020
Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccinesFrancois Busquet, Thomas Hartung, Giorgia Pallocca, et al.
ALTEX|August 17, 2021
Continuing animal tests on cosmetic ingredients for REACH in the EUJean Knight, Costanza Rovida, Reinhard Kreiling, et al.
ALTEX|April 4, 2020
New European Union statistics on laboratory animal use - what really counts!Francois Busquet, Andre Kleensang, Costanza Rovida, et al.
ALTEX|May 14, 2013
Advanced tests for skin and respiratory sensitization assessmentCostanza Rovida, Stefan F Martin, Manon Vivier, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
ALTEX|May 14, 2013
Alternative in vitro methods to characterize the role of Endocrine Active Substances (EASs) in hormone-targeted tissuesCostanza Rovida, Isabella De Angelis, Stefano Lorenzetti
ALTEX|December 2, 2011
How are reproductive toxicity and developmental toxicity addressed in REACH dossiers?Costanza Rovida, Fabiola Longo, Richard R Rabbit
ALTEX|October 10, 2025
Fish count, too - The animal toll of REACH aquatic toxicity testsJean Knight, Costanza Rovida, Kate Willett, et al.
Alternatives to Laboratory Animals : ATLA|June 6, 2014
ESNATS conference - the use of human embryonic stem cells for novel toxicity testing approachesCostanza Rovida, Manon Vivier, Bernward Garthoff, et al.
ALTEX|July 20, 2023
REACH out-numbered! The future of REACH and animal numbersCostanza Rovida, Francois Busquet, Marcel Leist, et al.
ALTEX|July 16, 2018
Animal testing and its alternatives - the most important omics is economicsLucy Meigs, Lena Smirnova, Costanza Rovida, et al.
Archives of Toxicology|May 25, 2020
Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccinesFrancois Busquet, Thomas Hartung, Giorgia Pallocca, et al.
ALTEX|August 17, 2021
Continuing animal tests on cosmetic ingredients for REACH in the EUJean Knight, Costanza Rovida, Reinhard Kreiling, et al.
ALTEX|April 4, 2020
New European Union statistics on laboratory animal use - what really counts!Francois Busquet, Andre Kleensang, Costanza Rovida, et al.
ALTEX|May 14, 2013
Advanced tests for skin and respiratory sensitization assessmentCostanza Rovida, Stefan F Martin, Manon Vivier, et al.
Pageof 6